{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:17:10Z","timestamp":1783660630293,"version":"3.55.0"},"reference-count":39,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"vor","delay-in-days":250,"URL":"http:\/\/www.diabetesjournals.org\/site\/license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CIHR MOP-84206"],"award-info":[{"award-number":["CIHR MOP-84206"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>The insulin resistance of mid- to late pregnancy poses a physiologic stress test for the pancreatic \u03b2-cells, which must respond by markedly increasing their secretion of insulin. This response is achieved through an expansion of \u03b2-cell mass induced by the hormones prolactin and human placental lactogen (HPL). Conversely, the furan fatty acid metabolite 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) has recently emerged as a negative regulator of \u03b2-cell function in pregnancy. Given their respective roles in the \u03b2-cell response to the stress test of gestation, we hypothesized that antepartum prolactin, HPL, and CMPF may relate to a woman\u2019s underlying glucoregulatory physiology and hence to her metabolic status after pregnancy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Three hundred and sixty-seven women underwent measurement of fasting serum prolactin, HPL, and CMPF in the late-2nd\/early-3rd trimester, followed by an oral glucose tolerance test (OGTT) at 3 months postpartum that enabled assessment of glucose tolerance, insulin sensitivity\/resistance, and \u03b2-cell function (Insulin Secretion-Sensitivity Index-2 [ISSI-2]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The postpartum OGTT identified 301 women with normal glucose tolerance (NGT) and 66 with prediabetes or diabetes. Serum prolactin in pregnancy was higher in women with postpartum NGT compared with those with postpartum prediabetes\/diabetes (mean 98.2 vs. 80.2 ng\/mL, P = 0.0003), whereas HPL and CMPF did not differ between the groups. On multiple linear regression analyses, antepartum prolactin was an independent determinant of postpartum ISSI-2 (\u03b2 = 0.0016, t = 2.96, P = 0.003). Furthermore, higher serum prolactin in pregnancy independently predicted a lower risk of postpartum prediabetes\/diabetes (odds ratio 0.50, 95% CI 0.35\u20130.72, P = 0.0002).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Serum prolactin in pregnancy predicts postpartum \u03b2-cell function and risk of prediabetes\/diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc16-0043","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T04:53:46Z","timestamp":1461732826000},"page":"1250-1258","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":59,"title":["Maternal Serum Prolactin and Prediction of Postpartum \u03b2-Cell Function and Risk of Prediabetes\/Diabetes"],"prefix":"10.2337","volume":"39","author":[{"given":"Ravi","family":"Retnakaran","sequence":"first","affiliation":[{"name":"Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada"},{"name":"Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Ye","sequence":"additional","affiliation":[{"name":"Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline K.","family":"Kramer","sequence":"additional","affiliation":[{"name":"Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada"},{"name":"Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Connelly","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Keenan Research Centre for Biomedical Science of St. Michael\u2019s Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Hanley","sequence":"additional","affiliation":[{"name":"Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada"},{"name":"Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Sermer","sequence":"additional","affiliation":[{"name":"Division of Obstetrics and Gynecology, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Zinman","sequence":"additional","affiliation":[{"name":"Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada"},{"name":"Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2016,4,26]]},"reference":[{"key":"2022031301125669800_B1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/157339909789804378","article-title":"Glucose tolerance status in pregnancy: a window to the future risk of diabetes and cardiovascular disease in young women","volume":"5","author":"Retnakaran","year":"2009","journal-title":"Curr Diabetes Rev"},{"key":"2022031301125669800_B2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1172\/JCI200524531","article-title":"Gestational diabetes mellitus","volume":"115","author":"Buchanan","year":"2005","journal-title":"J Clin Invest"},{"key":"2022031301125669800_B3","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.2337\/dc10-0351","article-title":"Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy","volume":"33","author":"Retnakaran","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301125669800_B4","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2337\/db10-0521","article-title":"Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus","volume":"59","author":"Xiang","year":"2010","journal-title":"Diabetes"},{"key":"2022031301125669800_B5","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1007\/s00125-013-3048-0","article-title":"Longitudinal changes in insulin sensitivity and beta cell function between women with and without a history of gestational diabetes mellitus","volume":"56","author":"Xiang","year":"2013","journal-title":"Diabetologia"},{"key":"2022031301125669800_B6","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.2337\/dc14-1529","article-title":"Each degree of glucose intolerance in pregnancy predicts distinct trajectories of \u03b2-cell function, insulin sensitivity, and glycemia in the first 3 years postpartum","volume":"37","author":"Kramer","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031301125669800_B7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00125-009-1321-z","article-title":"The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality","volume":"52","author":"Kahn","year":"2009","journal-title":"Diabetologia"},{"key":"2022031301125669800_B8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2337\/db14-0877","article-title":"New insights into gestational glucose metabolism: lessons learned from 21st century approaches","volume":"64","author":"Angueira","year":"2015","journal-title":"Diabetes"},{"key":"2022031301125669800_B9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MED.0b013e32834c800d","article-title":"Placental hormones and the control of maternal metabolism and fetal growth","volume":"18","author":"Newbern","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2022031301125669800_B10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/dmt.10.24","article-title":"Mechanisms in the adaptation of maternal \u03b2-cells during pregnancy","volume":"1","author":"Ernst","year":"2011","journal-title":"Diabetes Manag (Lond)"},{"key":"2022031301125669800_B11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-0031-1284353","article-title":"Prolactin and lactation as modifiers of diabetes risk in gestational diabetes","volume":"43","author":"Ramos-Rom\u00e1n","year":"2011","journal-title":"Horm Metab Res"},{"key":"2022031301125669800_B12","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1210\/en.2008-1003","article-title":"Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy","volume":"150","author":"Huang","year":"2009","journal-title":"Endocrinology"},{"key":"2022031301125669800_B13","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1210\/en.2008-1710","article-title":"Prolactin receptors are critical to the adaptation of islets to pregnancy","volume":"150","author":"Sorenson","year":"2009","journal-title":"Endocrinology"},{"key":"2022031301125669800_B14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cmet.2014.03.008","article-title":"The furan fatty acid metabolite CMPF is elevated in diabetes and induces \u03b2 cell dysfunction","volume":"19","author":"Prentice","year":"2014","journal-title":"Cell Metab"},{"key":"2022031301125669800_B15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.cmet.2014.03.020","article-title":"Lipotoxicity, \u03b2 cell dysfunction, and gestational diabetes","volume":"19","author":"Nolan","year":"2014","journal-title":"Cell Metab"},{"key":"2022031301125669800_B16","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/dc08-0972","article-title":"Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes","volume":"31","author":"Retnakaran","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031301125669800_B17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2337\/diab.28.12.1039","article-title":"Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance","volume":"28","author":"National Diabetes Data Group","year":"1979","journal-title":"Diabetes"},{"key":"2022031301125669800_B18","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.jcjd.2013.01.011","article-title":"Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome","volume":"37","author":"Goldenberg","year":"2013","journal-title":"Can J Diabetes"},{"key":"2022031301125669800_B19","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"2022031301125669800_B20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2022031301125669800_B21","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/oby.2008.307","article-title":"Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test","volume":"16","author":"Retnakaran","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"2022031301125669800_B22","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1464-5491.2009.02841.x","article-title":"Evaluation of proposed oral disposition index measures in relation to the actual disposition index","volume":"26","author":"Retnakaran","year":"2009","journal-title":"Diabet Med"},{"key":"2022031301125669800_B23","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1007\/s00125-015-3670-0","article-title":"Prolactin-stimulated survivin induction is required for beta cell mass expansion during pregnancy in mice","volume":"58","author":"Xu","year":"2015","journal-title":"Diabetologia"},{"key":"2022031301125669800_B24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.2173","article-title":"Serotonin regulates pancreatic beta cell mass during pregnancy","volume":"16","author":"Kim","year":"2010","journal-title":"Nat Med"},{"key":"2022031301125669800_B25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/db09-0050","article-title":"Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen","volume":"59","author":"Zhang","year":"2010","journal-title":"Diabetes"},{"key":"2022031301125669800_B26","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.1146812","article-title":"Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus","volume":"318","author":"Karnik","year":"2007","journal-title":"Science"},{"key":"2022031301125669800_B27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mce.2006.09.011","article-title":"Beneficial effects of prolactin and laminin on human pancreatic islet-cell cultures","volume":"263","author":"Labriola","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"2022031301125669800_B28","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1007\/s00125-011-2102-z","article-title":"Recombinant human prolactin promotes human beta cell survival via inhibition of extrinsic and intrinsic apoptosis pathways","volume":"54","author":"Terra","year":"2011","journal-title":"Diabetologia"},{"key":"2022031301125669800_B29","doi-asserted-by":"crossref","first-page":"30707","DOI":"10.1074\/jbc.M702607200","article-title":"Lactogens promote beta cell survival through JAK2\/STAT5 activation and Bcl-XL upregulation","volume":"282","author":"Fujinaka","year":"2007","journal-title":"J Biol Chem"},{"key":"2022031301125669800_B30","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/TP.0b013e3181d98af1","article-title":"Prolactin supplementation to culture medium improves beta-cell survival","volume":"89","author":"Yamamoto","year":"2010","journal-title":"Transplantation"},{"key":"2022031301125669800_B31","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.2337\/dc12-1893","article-title":"Circulating prolactin associates with diabetes and impaired glucose regulation: a population-based study","volume":"36","author":"Wang","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031301125669800_B32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6823-13-12","article-title":"Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes","volume":"13","author":"Balbach","year":"2013","journal-title":"BMC Endocr Disord"},{"key":"2022031301125669800_B33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tem.2009.11.001","article-title":"Expansion of beta-cell mass in response to pregnancy","volume":"21","author":"Rieck","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"2022031301125669800_B34","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet"},{"key":"2022031301125669800_B35","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.2337\/dc16-S015","article-title":"12. Management of Diabetes in Pregnancy","volume":"39","author":"American Diabetes Association","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031301125669800_B36","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1471-0528.2011.03083.x","article-title":"Missed opportunities for type 2 diabetes testing following gestational diabetes: a population-based cohort study","volume":"118","author":"Shah","year":"2011","journal-title":"BJOG"},{"key":"2022031301125669800_B37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"2022031301125669800_B38","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2337\/diabetes.50.6.1290","article-title":"High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program","volume":"50","author":"Federici","year":"2001","journal-title":"Diabetes"},{"key":"2022031301125669800_B39","doi-asserted-by":"crossref","first-page":"e28050","DOI":"10.1371\/journal.pone.0028050","article-title":"Altered insulin receptor signalling and \u03b2-cell cycle dynamics in type 2 diabetes mellitus","volume":"6","author":"Folli","year":"2011","journal-title":"PLoS One"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc16-0043","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/7\/1250\/626493\/dc160043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/7\/1250\/626493\/dc160043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T04:54:34Z","timestamp":1647147274000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/39\/7\/1250\/37356\/Maternal-Serum-Prolactin-and-Prediction-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,26]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,4,26]]},"published-print":{"date-parts":[[2016,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc16-0043","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,26]]}}}